Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
170 participants
OBSERVATIONAL
2022-03-01
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Results After DSAEK, UT-DSAEK and DMEK for Fuchs Endothelial Corneal Dystophy
NCT04424550
Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty
NCT05399095
DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery
NCT06013462
Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
NCT04527523
Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT
NCT02542644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DMEK-operated eyes without graft detachment
Eyes operated with DMEK without graft detachment
Descemet Membrane Endothelial Keratoplasty
DMEK-operated eyes
DMEK-operated with graft detachment
Eyes operated with DMEK with graft detachment
Descemet Membrane Endothelial Keratoplasty
DMEK-operated eyes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Descemet Membrane Endothelial Keratoplasty
DMEK-operated eyes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* all existing anterior segment anomalies
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional Metz-Thionville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Marc PERONE, MD
Role: PRINCIPAL_INVESTIGATOR
CHR Metz Thionville Hopital de Mercy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHR Metz-Thionville/Hopital de Mercy
Metz, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-10Obs-CHRMT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.